Spironolactone
- Product NDC
- 71335-0966
- 11-digit product format
- 713350966
- Labeler code
- 71335
- Product ID
- 71335-0966_e0c4a6b6-aa55-4281-8c84-29e1c126c8c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Spironolactone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA091426
- Marketing category
- ANDA
- Marketing start
- 2010-08-02
- Substance
- SPIRONOLACTONE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Spironolactone
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SPIRONOLACTONE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 27O7W4T232 |
| Rxcui | 198222 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71335-0966-1 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-1 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-2 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-2 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-3 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-3 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-4 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-4 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-5 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-5 | 2024-05-17 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
| 71335-0966-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-4518-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE tablets, for oral use Initial U.S. Approval: 1960 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-0966-1 | Spironolactone | 100 in 1 BOTTLE | TABLET | 100 | | 6 |
| 71335-0966-2 | Spironolactone | 3 in 1 BOTTLE | TABLET | 3 | | 6 |
| 71335-0966-3 | Spironolactone | 30 in 1 BOTTLE | TABLET | 30 | | 6 |
| 71335-0966-4 | Spironolactone | 90 in 1 BOTTLE | TABLET | 90 | | 6 |
| 71335-0966-5 | Spironolactone | 60 in 1 BOTTLE | TABLET | 60 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-0966 | SPIRONOLACTONE TABLET [BRYANT RANCH PREPACK] | 6 | Current NDC, Legacy NDC, 5 package rows | 20241116_31aeab13-8f71-49f1-b101-8b0abb21b0dc.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0966-1 | 71335096601 | 100 TABLET in 1 BOTTLE (71335-0966-1) | 100 tablet | 2024-10-30 | 0000-00-00 | No | No | Current |
| 71335-0966-2 | 71335096602 | 3 TABLET in 1 BOTTLE (71335-0966-2) | 3 tablet | 2024-10-30 | 0000-00-00 | No | No | Current |
| 71335-0966-3 | 71335096603 | 30 TABLET in 1 BOTTLE (71335-0966-3) | 30 tablet | 2018-10-09 | 0000-00-00 | No | No | Current |
| 71335-0966-4 | 71335096604 | 90 TABLET in 1 BOTTLE (71335-0966-4) | 90 tablet | 2024-10-30 | 0000-00-00 | No | No | Current |
| 71335-0966-5 | 71335096605 | 60 TABLET in 1 BOTTLE (71335-0966-5) | 60 tablet | 2024-10-30 | 0000-00-00 | No | No | Current |